The difference is that retatrutide adds glucagon receptor activity to GIP and GLP-1 activity, which is why the obesity research community is watching its long-term data closely
This genetic insight allows your clinician to select the optimal compound, starting dose, and escalation timeline tailored to your biology
May your thyroid levels stay balanced, your weight loss stay consistent, and your monitoring stay on schedule.
IV therapy is generally considered safe for appropriate candidates when administered by licensed clinicians under physician supervised protocols
The primary endpoint of this trial will be the evaluation of the decrease in heavy drinking days while, as secondary endpoints, the change in alcohol consumption from baseline, smoking status, the alcohol cue reactivity, evaluated by fMRI and plasma phosphatidyl ethanol and brain GABA levels, will be assessed